I looked at the nominations process earlier. You needed to fill out a lot of personal information for a nominee that we as patients don't have.
I think we're at a crucial point for funding. WPI is ready to do studies on immune systems and treatments and the conference conclusion was wait, or reapply to NIH that has rejected your proposals, and has no money allocated. CFSAC has to push for us. It is the scientists and doctors who know the ME/CFS patient population that push for us.
I'm all for Dr. Mellors doing studies, but I am concerned about him representing ME/CFS patients on CFSAC. He doesn't seem to know the patient population, and I think he is refering to his own skepticism, even after sitting through all the lectures by Ruscetti et al. When I watched the Q and A a second time I noticed, as well as thinking contamination of supplements is more likely than the retrovirus found, wanting to split up XMRV research in CFS and prostate cancer (studies are separate, but more can be learned at this point by having the conferences together-like the knowledge Dr. Singh brings to the table), he didn't recognize the many reasons for the 0% findings by the CDC and other small groups who used general fatigue cohorts, different primers, unactivated blood, old samples, PCR only, heparin tubes, that were discussed at the conference.
0% prevalence in the bed bound- that would mean the Swedish study which we can't see yet, in a very different region? Or he doesn't get the psychologist cohorts?
His questions may represent those of other scientists at large, but as Coffin or someone commented he is already on many powerful committees.
For our representatives we should ask, are they for immediate research funds for XMRV and ME/CFS? Will they support funds for WPI and Centers for Excellence for treatment and immune studies now? Are they for the advanced research team with the patients, the facilities, the testing, the immune panels, the virochip, going forward (while others learn to test)?
His concern right now seems to be catching up the rest of the scientists, which is the stand the NIH has taken by not funding WPI. It will take some time for them all to be on the same page. That isn't the need of the patients like me who have vertigo and chest pain and wonder if we can hug our relatives and friends.
Yes, I think Mellors and others are against funding for Centers for Excellence until there is standardized testing. The CDC and other groups want to have their own tests, have not tried WPI's methods, and are holding back the more advanced research.
I don't know about Dodd specifically, but some of the blood bank people seem to taken this very seriously and learned a lot.
Some of these people are definitely not jumping on the XMRV bandwagon and they have real questions about it and they are not alone. Read the latest article in Science - the field is described as being in a 'zone of chaos'.
That zone of chaos quote was taken out of context. A poor article for a science mag with all the data presented at the conference. Coffin was talking about being in the first year of research like HIV.
http://www.facebook.com/notes/xmrv-...t-international-xmrv-workshop-qa/438284026796
Dr. Coffin. You have to be reminded that it’s been less than a year since people, most of us have been seriously thinking about dealing with these issues. It’s really quite a short time. It takes a long time, to set up, say to set up the blood working group panel, it’s been probably six months of talking and deciding and so on before we began to get samples really in… so it’s only couple of months that we’ve been working on that. So I’m quite optimistic that say within the next year there will be a synthesis of this to the point where not necessarily everyone’s using exactly the same assay – you don’t do that with HIV – you have different assays designed for different purposes. And I think we’ll head toward that fairly quickly now I would predict. But right now we’re still in a zone of chaos where since we don’t have agreement on almost anything in this we have to work toward that right now. But I’m optimistic we’ll get there soon.